Issue 5, 2014

Structure-based drug design of chromone antagonists of the adenosine A2A receptor

Abstract

The structure-guided optimisation of a hit series of chromone derivatives, previously identified using virtual screening of homology models of the adenosine A2A receptor, has led to the discovery of potent, selective and ligand efficient antagonists. Lipophilic hotspots and calculated water networks were modelled within the receptor binding site to facilitate rational ligand design.

Graphical abstract: Structure-based drug design of chromone antagonists of the adenosine A2A receptor

Supplementary files

Article information

Article type
Concise Article
Submitted
04 Nov 2013
Accepted
30 Dec 2013
First published
21 Jan 2014

Med. Chem. Commun., 2014,5, 571-575

Author version available

Structure-based drug design of chromone antagonists of the adenosine A2A receptor

S. P. Andrews, J. S. Mason, E. Hurrell and M. Congreve, Med. Chem. Commun., 2014, 5, 571 DOI: 10.1039/C3MD00338H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements